Delays to clinical trial initiation and poor recruitment levels are endangering the UK's status as a leading nation for commercial research. • Source: Shutterstock
Learn what's happening at the US FDA. On the go.
Derrick Gingery and the team bring you a weekly "Drug Fix".
